Skip to main content
. Author manuscript; available in PMC: 2014 Nov 14.
Published in final edited form as: J Med Chem. 2013 Oct 31;56(21):10.1021/jm401248x. doi: 10.1021/jm401248x

Figure 7.

Figure 7

In vivo therapeutic efficacy of compound 19 compared to 1 in inhibiting growth of xenograft tumors (triple-negative breast cancer cell line MDA-MB-231) in mice (i.p.) at 5 mg/kg: (A) average tumor size changes; (B) average body weight changes. Values are mean ± SE of three independent experiments. Statistical significance was determined using one-way ANOVA (p < 0.0001).